Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region.
Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.
Research Scope The key objectives of this growth insights study are to track the transformations in the prenatal genetic test market landscape in Europe for 2016-2021. The study aims at identifying growth opportunities across the market and suggesting most profitable business models to market players.
Furthermore, the study provides an in-depth revenue and market analysis of 4 key segments within the prenatal landscape: NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers, restraints, competitive developments, key mergers and acquisitions (MandAs), and investment opportunities. Key trends across the market with respect to physician and patient attitudes toward prenatal genetic screening and its probable impact on growth are analyzed. Additionally, top growth opportunities, profiles of game-changing companies, disruptive technologies and innovative business models, along with strategic recommendations are included.
Key Issues Addressed Which are the most promising segments in the EU prenatal genetic testing market? Where is the most interest in terms of funding and innovation? What are the most favorable business models across the prenatal testing market in Europe? How are companies coping with the market drawbacks and needs? What are some of the most disruptive products in this market? Who are the key players in the market? What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
Our reports have been used by over 10K customers, including:
2018 Global Nucleic Acid Testing (NAT) Market: Supplier Country Shares and Strategic Assessments of Key Players This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative...
2019 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Emerging Technologies and Strategic Profiles of Leading Suppliers This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA...
The global liquid biopsy market is expected to reach nearly US$ 6.5 Billion by 2026. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products...
316 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis...
Global animal genetics market is projected to grow at a CAGR of 6.5% The global animal genetics market is projected to reach USD 5.8 billion by 2023 from USD 4.2 billion in 2018, at a CAGR of 6.5 % during the forecast period. Factors such as rising consumption for animal-derived protein, growing population and rapid urbanization...
134 pages •
By Infiniti Research Limited
• Dec 2018
About this market Increasing stem cell and biomedical research to drive growth in the market. Stem cells are used in drug development to provide personalized medicine. Biotechnology reagents are used as biomarkers in stem cell research for visualization of cell and tissue lines. Technavio’s analysts have predicted that...
82 pages •
By International Market Analysis Research and Consult
• Dec 2018
China Genetic Testing Market reached a value of US$ 1.43 Billion in 2017. Genetic testing, also known as DNA testing, provides the determination of bloodlines and the genetic diagnosis of vulnerabilities to diseases that can be inherited. It determines changes in chromosomes, genes, or proteins. The results obtained from a genetic test can...
211 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for Electrophoresis Equipment and Supplies in US$ Thousand by the following Product Segments: Gel Electrophoresis Systems, Capillary Electrophoresis Systems, and Electrophoresis Gels/Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.